IPSEN |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.6 EUR | +1.01% |
|
-2.27% | +11.77% |
| May. 31 | Ipsen: new employee shareholding operation | CF |
| May. 28 | Ipsen S.A. Approves Dividend, Payable on 3 June 2024 | CI |
ETFs positioned on Ipsen
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.83% | 2 M€ | +10.72% | ||
| 0.43% | 242 M€ | +8.57% | ||
| 0.31% | 3 M€ | +9.95% | - | |
| 0.24% | 1,083 M€ | +4.80% | ||
| 0.24% | 5 M€ | +4.56% | ||
| 0.16% | 14 M€ | +5.66% | - | |
| 0.16% | 5 M€ | +10.09% | - | |
| 0.10% | 2 M€ | +9.19% | - | |
| 0.10% | 2 M€ | -.--% | - | |
| 0.09% | 17 M€ | +6.09% | - | |
| 0.05% | 6 M€ | -.--% | - | |
| 0.04% | 6 M€ | -.--% | ||
| 0.03% | 32 M€ | +6.87% | - | |
| 0.03% | 10 M€ | -3.35% | - | |
| 0.02% | 7 M€ | +0.11% | - | |
| 0.02% | 23 M€ | -.--% | - | |
| 0.02% | 786 M€ | -.--% | ||
| 0.01% | 206 M€ | -.--% | ||
| 0.01% | 607 M€ | +0.05% | - | |
| 0.01% | 1,166 M€ | +0.26% | - | |
| 0.01% | 283 M€ | +19.73% | ||
| 0.00% | 45 M€ | -.--% | - | |
| 0.00% | 284 M€ | -.--% | ||
| 0.00% | 391 M€ | +7.63% | - | |
| 0.00% | 34 M€ | +7.50% | - | |
| 0.00% | 34 M€ | +3.86% | - |
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
Pharmaceuticals
Calendar
2024-07-23
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120.6
EUR
Average target price
126.4
EUR
Spread / Average Target
+4.81%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.77% | 10.8B | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- IPN Stock
- Funds and ETFs Ipsen
